These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32718292)

  • 21. Neurological manifestations of coronavirus disease 2019: exploring past to understand present.
    Desai I; Manchanda R; Kumar N; Tiwari A; Kumar M
    Neurol Sci; 2021 Mar; 42(3):773-785. PubMed ID: 33428055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological involvement in the respiratory manifestations of COVID-19 patients.
    Tan BH; Liu JM; Gui Y; Wu S; Suo JL; Li YC
    Aging (Albany NY); 2021 Feb; 13(3):4713-4730. PubMed ID: 33582654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does COVID-19 contribute to development of neurological disease?
    Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
    Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems.
    Karimi L; Sales C; Crewther SG; Wijeratne T
    Front Neurol; 2020; 11():565665. PubMed ID: 33414753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [SARS-CoV-2 and neurological disorders: the revelance of biomarkers?].
    Bigot-Corbel E; Lanore A; Raulet C; Delorme C; Azulay JP; Lehmann S; Beaudeux JL; Beauvieux MC; Sapin V; Peoc'h K; Rucheton B;
    Ann Biol Clin (Paris); 2021 Feb; 79(1):7-16. PubMed ID: 33570039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19).
    Baig AM; Sanders EC
    J Med Virol; 2020 Oct; 92(10):1845-1857. PubMed ID: 32492193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological complications in COVID-19 - a diagnostic challenge.
    Vacaras V; Frunze S; Cordos AM
    J Med Life; 2021; 14(2):216-224. PubMed ID: 34104245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroinvasive potential of SARS-CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim?
    Franca RA; Ugga L; Guadagno E; Russo D; Del Basso De Caro M
    APMIS; 2021 Feb; 129(2):37-54. PubMed ID: 33098147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathies and neurological dysfunction induced by coronaviruses.
    Gholami M; Safari S; Ulloa L; Motaghinejad M
    J Neurovirol; 2021 Jun; 27(3):380-396. PubMed ID: 33983506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature.
    Di Carlo DT; Montemurro N; Petrella G; Siciliano G; Ceravolo R; Perrini P
    J Neurol; 2021 May; 268(5):1561-1569. PubMed ID: 32740766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential neuroinvasive and neurotrophic properties of SARS-CoV-2 in pediatric patients: comparison of SARS-CoV-2 with non-segmented RNA viruses.
    Chen X
    J Neurovirol; 2020 Dec; 26(6):929-940. PubMed ID: 33057966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.
    Özdağ Acarli AN; Samanci B; Ekizoğlu E; Çakar A; Şirin NG; Gündüz T; Parman Y; Baykan B
    Noro Psikiyatr Ars; 2020 Jun; 57(2):154-159. PubMed ID: 32550783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nervous system involvement in SARS-coronavirus infection: a review on lessons learned from the previous outbreaks, ongoing pandemic and what to expect in the future.
    Bhatti AUR; Zreik J; Yolcu YU; Alvi MA; Abode-Iyamah K; Quinones-Hinojosa A; Bydon M
    Int J Neurosci; 2022 Sep; 132(9):930-938. PubMed ID: 33208006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comprehensive Review of COVID-19 Associated Neurological Manifestations.
    Aggarwal CS; Walser S; Bhandari A; Garg N; McClafferty B; Ramgobin D; Golamari R; Sahu N; Kumar A; Jain R
    S D Med; 2020 Dec; 73(12):569-571. PubMed ID: 33684975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The myocardial and neuronal infectivity of SARS-CoV-2 and detrimental outcomes.
    Herbert E; Fournier D; Al-Shaqha WM; Chahine M
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1128-1136. PubMed ID: 34546143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?
    Al-Harthi L; Campbell E; Schneider JA; Bennett DA
    AIDS Res Hum Retroviruses; 2021 Apr; 37(4):255-265. PubMed ID: 32683890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19.
    Alshebri MS; Alshouimi RA; Alhumidi HA; Alshaya AI
    SN Compr Clin Med; 2020; 2(11):2037-2047. PubMed ID: 33083695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.